サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1669355

抗生物質の世界市場レポート 2025

Antibiotics Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.46円
抗生物質の世界市場レポート 2025
出版日: 2025年02月28日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

抗生物質市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）5.5％で1,106億5,000万米ドルに成長します。予測期間の成長は、世界の健康脅威、ヘルスケア支出の増加、政府のイニシアティブと規制、国際的な協力関係の強化に起因しています。予測期間における世界の動向には、経口用抗生物質の開発、抗生物質開発のための連携とパートナーシップ、規制上のインセンティブとパスウェイ、ヘルスケアにおける抗菌薬スチュワードシッププログラム、抗生物質アクセスのための世界ヘルスイニシアチブなどが含まれます。

予想される細菌感染症の増加は、抗生物質市場の重要な促進要因になると考えられています。微細な単細胞生物によって引き起こされる細菌感染症は、細菌の増殖を阻害する抗生物質を使用することで、効果的な治療や予防が可能となります。2023年2月に世界保健機関（WHO）が報告した事例では、2022年に世界30カ国がコレラの流行に見舞われ、2021年には過去10年間で最高の症例致死率（CFR）1.9％を記録したことが浮き彫りになった。さらに、2023年4月の米国疾病予防管理センター（Centers for Disease Control and Prevention）のデータでは、2021年の米国における梅毒患者数は2020年に比べて32％増加しました。このような事例は細菌感染の急増を裏付けるものであり、抗生物質の市場需要を後押ししています。

急増する人口によるヘルスケアニーズの高まりが、抗生物質市場の成長軌道を牽引すると予想されます。急増する人口は、ヘルスケアの課題に効果的に対処するため、医療資源、サービス、インフラの増加を要求しています。抗生物質は、細菌感染の治療、伝染病の予防、公衆衛生の保護など、これらのニーズに対応する上で極めて重要な役割を果たしています。これらの医薬品は、様々な病気の管理、罹患率や死亡率の低下、手術、化学療法、免疫抑制療法などの医療介入の支援に役立っています。適切な抗生物質の使用は、増加する人口のヘルスケア需要を満たし、世界の健康基準を維持するために不可欠です。特に、2022年9月の米国国勢調査局のデータでは、米国の居住人口が0.4%増加し、2022年には333,287,557人に達することが示されており、拡大する人口の医療ニーズに対応する上で抗生物質が不可欠な役割を果たすことが強調され、抗生物質市場を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界抗生物質PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界の抗生物質市場：成長率分析
  • 世界の抗生物質市場の実績：規模と成長, 2019-2024
  • 世界の抗生物質市場の予測：規模と成長, 2024-2029, 2034F
  • 世界抗生物質総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の抗生物質市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ペニシリン
  • セファロスポリン
  • アミノグリコシド
  • テトラサイクリン
  • マクロライド
  • フルオロキノロン
  • スルホンアミド
  • その他のクラス
  • 世界の抗生物質市場活動範囲別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 広域抗生物質
  • 狭域抗生物質
  • 世界の抗生物質市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • オーラル
  • 静脈内
  • その他のルート
  • 世界の抗生物質市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • 世界の抗生物質市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 皮膚感染症
  • 呼吸器感染症
  • 尿路感染症
  • 敗血症
  • 耳の感染症
  • 胃腸感染症
  • その他の用途
  • 世界の抗生物質市場ペニシリンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 天然ペニシリン
  • アミノペニシリン
  • ペニシリナーゼ耐性ペニシリン
  • 広域スペクトルペニシリン
  • 世界の抗生物質市場セファロスポリンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 第一世代
  • 第二世代
  • 第三世代
  • 第4世代
  • 第5世代
  • 世界の抗生物質市場、アミノグリコシドのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ゲンタマイシン
  • トブラマイシン
  • アミカシン
  • ネオマイシン
  • 世界の抗生物質市場、テトラサイクリンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • テトラサイクリン
  • ドキシサイクリン
  • ミノサイクリン
  • オキシテトラサイクリン
  • 世界の抗生物質市場マクロライドのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • エリスロマイシン
  • アジスロマイシン
  • クラリスロマイシン
  • 世界の抗生物質市場、フルオロキノロンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • シプロフロキサシン
  • レボフロキサシン
  • モキシフロキサシン
  • オフロキサシン
  • 世界の抗生物質市場、スルホンアミドのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • スルファメトキサゾール
  • スルファジアジン
  • スルファサラジン
  • 世界の抗生物質市場、その他のクラスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 糖ペプチド
  • リポペプチド
  • ストレプトグラミン
  • ポリミキシン

第7章 地域別・国別分析

  • 世界の抗生物質市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の抗生物質市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 抗生物質市場：競合情勢
  • 抗生物質市場：企業プロファイル
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Bayer AG
  • Novartis AG
  • Sanofi SA
  • Bristol Myers Squibb（BMS）
  • AstraZeneca plc
  • Abbott Laboratories
  • GlaxoSmithKline plc（GSK）
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Boehringer Ingelheim
  • Viatris Inc
  • Teva Pharmaceutical Industries Ltd.
  • Astellas Pharma Inc.
  • Daiichi Sankyo Company
  • Sun Pharmaceutical Industries Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 抗生物質市場2029：新たな機会を提供する国
  • 抗生物質市場2029：新たな機会を提供するセグメント
  • 抗生物質市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r24665

Antibiotics, a class of medications, function by either eradicating bacteria or impeding their growth, aiding the body's immune system in eliminating infections. They are employed in the treatment of diverse bacterial infections.

The primary drug classes encompass penicillin, cephalosporin, aminoglycosides, tetracycline, macrolides, fluoroquinolones, sulfonamides, and others. Penicillin, derived from the fungus Penicillium, constitutes a group of antibiotics. The spectrum of activity includes broad-spectrum and narrow-spectrum antibiotics. These antibiotics can be administered through various routes, such as oral, intravenous, and others, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies. They find applications in treating a range of infections, including skin infections, respiratory infections, urinary tract infections, septicemia, ear infections, gastrointestinal infections, among others.

The antibiotics market research report is one of a series of new reports from The Business Research Company that provides antibiotics market statistics, including the antibiotics industry global market size, regional shares, competitors with an antibiotics market share, detailed antibiotics market segments, market trends, and opportunities, and any further data you may need to thrive in the antibiotics industry. This antibiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antibiotics market size has grown strongly in recent years. It will grow from $84.68 billion in 2024 to $89.31 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to increased incidence of infectious diseases, growing population and urbanization, rising healthcare awareness, access to healthcare services, prevalence of antibiotic-resistant strains

The antibiotics market size is expected to see strong growth in the next few years. It will grow to $110.65 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to global health threats, rising healthcare expenditure, government initiatives and regulations, increased international collaboration. Major trends in the forecast period include development of oral antibiotics, collaboration and partnerships for antibiotic development, regulatory incentives and pathways, antimicrobial stewardship programs in healthcare, global health initiatives for antibiotic access.

The anticipated rise in bacterial infections is poised to be a significant driver for the antibiotics market. Bacterial infections, caused by microscopic single-celled organisms, can be effectively treated and prevented using antibiotics, which impede bacterial growth. A case in point from February 2023, as reported by the World Health Organization, highlighted that 30 countries worldwide were affected by a cholera epidemic in 2022, recording the highest case fatality ratio (CFR) of 1.9% in a decade in 2021. Moreover, data from the Centers for Disease Control and Prevention in April 2023 indicated a 32% increase in syphilis cases in the United States in 2021 compared to 2020. These instances underscore the surge in bacterial infections, thereby propelling the demand for antibiotics within the market.

The escalating healthcare needs of a burgeoning population are expected to drive the growth trajectory of the antibiotics market. The burgeoning population demands increased medical resources, services, and infrastructure to address healthcare challenges effectively. Antibiotics play a pivotal role in addressing these needs by treating bacterial infections, preventing contagious diseases, and safeguarding public health. These medications aid in managing various illnesses, reducing morbidity and mortality rates, supporting medical interventions such as surgeries, chemotherapy, and immunosuppressive therapies. Adequate antibiotic usage is essential to meet the healthcare demands of a growing population and uphold global health standards. Notably, data from the U.S. Census Bureau in September 2022 indicated a 0.4% increase in the United States' resident population, reaching 333,287,557 in 2022, underscoring the imperative role of antibiotics in addressing the healthcare needs of an expanding populace, thereby driving the antibiotics market.

A prominent trend in the antibiotics market involves the rise in new product approvals, with major companies securing regulatory endorsements for their innovative antibiotic formulations. For instance, in January 2023, Alkem Laboratories Ltd., an Indian pharmaceutical firm, introduced Zidavi, a fusion of ceftazidime and avibactam. This medication is specifically designed to address complicated urinary tract infections, intra-abdominal infections, and pneumonia caused by multi-drug resistant (MDR) Gram-negative bacteria. Zidavi stands out as a pivotal advancement in combating antibiotic resistance, serving as one of the few antibiotics effective against MDR Gram-negative bacteria.

Leading companies in the antibiotics market are adopting a strategic partnership approach to improve access to novel antibacterial drugs. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve shared success and benefits. For example, in June 2024, Orchid Pharma Limited, an India-based pharmaceutical company, announced a partnership with Cipla Limited, another India-based pharmaceutical company, to efficiently launch and distribute Cefepime-Enmetazobactam in India. This collaboration combines Orchid Pharma's expertise in innovative drug development with Cipla's vast distribution network to introduce Cefepime-Enmetazobactam, an antibiotic approved for treating complicated urinary tract infections and pneumonia. The goal is to increase access to this essential medication throughout India, while tackling the rising issue of antimicrobial resistance (AMR) and encouraging responsible antibiotic use among healthcare providers.

In July 2022, Innoviva Inc., a US-based healthcare-focused asset management company, completed the acquisition of Entasis Therapeutics Holdings Inc. for an undisclosed amount. This strategic move aims to enhance Innoviva's portfolio by introducing first-in-class antibiotics designed to address multidrug-resistant Gram-negative bacteria. The acquisition not only contributes to diversification but also facilitates the expansion of Innoviva's customer base. Entasis Therapeutics Holdings Inc., a US-based late-stage clinical biopharmaceutical company operating in the antibiotics market, is dedicated to developing, manufacturing, and marketing novel antibacterial products.

Major companies operating in the antibiotics market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb (BMS), AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim, Viatris Inc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Sun Pharmaceutical Industries Limited, Cipla Ltd., Ferring Pharmaceuticals, Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Limited, Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Spero Therapeutics Inc., Nabriva Therapeutics Plc

North America was the largest region in the antibiotics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antibiotics market consists of sales of Glycopeptides, Clindamycin, and Quinolones. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antibiotics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antibiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antibiotics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Drug Class: Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Macrolides, Fluoroquinolones, Sulfonamides, Other Classes
  • 2) By Spectrum Of Activity: Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic
  • 3) By Route Of Administration: Oral, Intravenous, Other Routes
  • 4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
  • 5) By Application: Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infections, Gastrointestinal Infections, Other Applications
  • Subsegments:
  • 1) By Penicillin: Natural Penicillins; Aminopenicillins; Penicillinase-resistant Penicillins; Extended-spectrum Penicillins
  • 2) By Cephalosporin: First-generation; Second-generation; Third-generation; Fourth-generation; Fifth-generation
  • 3) By Aminoglycosides: Gentamicin; Tobramycin; Amikacin; Neomycin
  • 4) By Tetracycline: Tetracycline; Doxycycline; Minocycline; Oxytetracycline
  • 5) By Macrolides: Erythromycin; Azithromycin; Clarithromycin
  • 6) By Fluoroquinolones: Ciprofloxacin; Levofloxacin; Moxifloxacin; Ofloxacin
  • 7) By Sulfonamides: Sulfamethoxazole; Sulfadiazine; Sulfasalazine
  • 8) By Other Classes: Glycopeptides; Lipopeptides; Streptogramins; Polymyxins
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche AG; Merck & Co Inc.; AbbVie Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antibiotics Market Characteristics

3. Antibiotics Market Trends And Strategies

4. Antibiotics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Antibiotics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Antibiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Antibiotics Market Growth Rate Analysis
  • 5.4. Global Antibiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Antibiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Antibiotics Total Addressable Market (TAM)

6. Antibiotics Market Segmentation

  • 6.1. Global Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Penicillin
  • Cephalosporin
  • Aminoglycosides
  • Tetracycline
  • Macrolides
  • Fluoroquinolones
  • Sulfonamides
  • Other Classes
  • 6.2. Global Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Broad-spectrum Antibiotic
  • Narrow-spectrum Antibiotic
  • 6.3. Global Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Intravenous
  • Other Routes
  • 6.4. Global Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • 6.5. Global Antibiotics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Skin Infections
  • Respiratory Infections
  • Urinary Tract Infections
  • Septicemia
  • Ear Infections
  • Gastrointestinal Infections
  • Other Applications
  • 6.6. Global Antibiotics Market, Sub-Segmentation Of Penicillin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Natural Penicillins
  • Aminopenicillins
  • Penicillinase-resistant Penicillins
  • Extended-spectrum Penicillins
  • 6.7. Global Antibiotics Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • First-generation
  • Second-generation
  • Third-generation
  • Fourth-generation
  • Fifth-generation
  • 6.8. Global Antibiotics Market, Sub-Segmentation Of Aminoglycosides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gentamicin
  • Tobramycin
  • Amikacin
  • Neomycin
  • 6.9. Global Antibiotics Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tetracycline
  • Doxycycline
  • Minocycline
  • Oxytetracycline
  • 6.10. Global Antibiotics Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Erythromycin
  • Azithromycin
  • Clarithromycin
  • 6.11. Global Antibiotics Market, Sub-Segmentation Of Fluoroquinolones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ciprofloxacin
  • Levofloxacin
  • Moxifloxacin
  • Ofloxacin
  • 6.12. Global Antibiotics Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sulfamethoxazole
  • Sulfadiazine
  • Sulfasalazine
  • 6.13. Global Antibiotics Market, Sub-Segmentation Of Other Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glycopeptides
  • Lipopeptides
  • Streptogramins
  • Polymyxins

7. Antibiotics Market Regional And Country Analysis

  • 7.1. Global Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antibiotics Market

  • 8.1. Asia-Pacific Antibiotics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antibiotics Market

  • 9.1. China Antibiotics Market Overview
  • 9.2. China Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antibiotics Market

  • 10.1. India Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antibiotics Market

  • 11.1. Japan Antibiotics Market Overview
  • 11.2. Japan Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antibiotics Market

  • 12.1. Australia Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antibiotics Market

  • 13.1. Indonesia Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antibiotics Market

  • 14.1. South Korea Antibiotics Market Overview
  • 14.2. South Korea Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antibiotics Market

  • 15.1. Western Europe Antibiotics Market Overview
  • 15.2. Western Europe Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antibiotics Market

  • 16.1. UK Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antibiotics Market

  • 17.1. Germany Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antibiotics Market

  • 18.1. France Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antibiotics Market

  • 19.1. Italy Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antibiotics Market

  • 20.1. Spain Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antibiotics Market

  • 21.1. Eastern Europe Antibiotics Market Overview
  • 21.2. Eastern Europe Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antibiotics Market

  • 22.1. Russia Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antibiotics Market

  • 23.1. North America Antibiotics Market Overview
  • 23.2. North America Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antibiotics Market

  • 24.1. USA Antibiotics Market Overview
  • 24.2. USA Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antibiotics Market

  • 25.1. Canada Antibiotics Market Overview
  • 25.2. Canada Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antibiotics Market

  • 26.1. South America Antibiotics Market Overview
  • 26.2. South America Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antibiotics Market

  • 27.1. Brazil Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antibiotics Market

  • 28.1. Middle East Antibiotics Market Overview
  • 28.2. Middle East Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antibiotics Market

  • 29.1. Africa Antibiotics Market Overview
  • 29.2. Africa Antibiotics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Antibiotics Market, Segmentation By Spectrum Of Activity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antibiotics Market Competitive Landscape And Company Profiles

  • 30.1. Antibiotics Market Competitive Landscape
  • 30.2. Antibiotics Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Antibiotics Market Other Major And Innovative Companies

  • 31.1. Bayer AG
  • 31.2. Novartis AG
  • 31.3. Sanofi SA
  • 31.4. Bristol Myers Squibb (BMS)
  • 31.5. AstraZeneca plc
  • 31.6. Abbott Laboratories
  • 31.7. GlaxoSmithKline plc (GSK)
  • 31.8. Eli Lilly and Company
  • 31.9. Gilead Sciences Inc.
  • 31.10. Boehringer Ingelheim
  • 31.11. Viatris Inc
  • 31.12. Teva Pharmaceutical Industries Ltd.
  • 31.13. Astellas Pharma Inc.
  • 31.14. Daiichi Sankyo Company
  • 31.15. Sun Pharmaceutical Industries Limited

32. Global Antibiotics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antibiotics Market

34. Recent Developments In The Antibiotics Market

35. Antibiotics Market High Potential Countries, Segments and Strategies

  • 35.1 Antibiotics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Antibiotics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Antibiotics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer